Benzinga's Top Initiations
Analysts at JP Morgan initiated coverage on Intel Corporation (NASDAQ: INTC) with a Overweight rating. The target price for Intel is set to $40. Intel shares closed at $32.06 on Monday.
Merion Capital initiated coverage on OFG Bancorp (NYSE: OFG) with a Outperform rating. The target price for OFG Bancorp is set to $12. OFG Bancorp shares closed at $6.30 on Monday.
Analysts at Guggenheim Securities initiated coverage of WPX Energy Inc (NYSE: WPX) with a Buy rating. WPX Energy shares closed at $4.96 on Monday.
Analysts at Oppenheimer initiated coverage on FMC Technologies, Inc. (NYSE: FTI) with a Perform rating. FMC Technologies shares closed at $25.44 on Monday.
Credit Suisse initiated coverage on Petroleo Brasileiro SA Petrobras (ADR) (NYSE: PBR) with a Underperform rating. The target price for Petrobras is set to $2. Petrobras shares closed at $3.70 on Monday.
Analysts at Chardan Capital initiated coverage on IDI, Inc. (NYSE: IDI) with a Buy rating. The target price for IDI is set to $12.50. IDI shares closed at $5.60 on Monday.
Oppenheimer initiated coverage on Core Laboratories N.V. (NYSE: CLB) with a Perform rating. Core Laboratories shares closed at $93.72 on Monday.
Empire Asset Management initiated coverage of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) with a Sell rating. The target price for Sucampo Pharmaceuticals is set to $7. Sucampo Pharmaceuticals shares closed at $14.26 on Monday.
Analysts at Oppenheimer initiated initiated coverage on National-Oilwell Varco, Inc. (NYSE: NOV) with a Perform rating. National-Oilwell Varco shares closed at $29.94 on Monday.
Analysts at William Blair initiated coverage on Lennox International Inc. (NYSE: LII) with a Outperform rating. Lennox International shares closed at $116.76 on Monday.
Latest Ratings for IDI
Date | Firm | Action | From | To |
---|---|---|---|---|
Jul 2016 | Barrington Research | Initiates Coverage on | Outperform | |
Jan 2016 | Chardan Capital | Initiates Coverage on | Buy | |
Jan 2014 | Barclays | Downgrades | Equal-Weight | Underweight |
View More Analyst Ratings for IDI
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top InitiationsInitiation Analyst Ratings